The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

Upgrade your portfolio! C3.ai is a strong buy with explosive growth, top-tier partnerships, and AI exposure at a discount.

C3.ai Inc (AI) is winning back investors with a management shake-up that could redefine its future after CEO and founder Tom ...

This has led to strong growth for the company, with C3.ai's revenue rising 25% year over year in fourth-quarter fiscal year 2025 (ending April 30). It also expects strong growth for FY 2026, with ...

HII (HII), America’s largest military shipbuilder, and C3 AI (NYSE: AI), the Enterprise AI application software company, have recently announced a strategic partnership to expand digital technologies ...

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.

Spectral Capital Corporation (OTC: FCCN), a technology company focused on the convergence of artificial intelligence and ...

The new AI-focused ETF is putting your money where its mouth is, so to speak, by utilizing the very technology it's investing ...

Review the current C3.ai Inc Ordinary Shares - Class A (AI:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if AI is the best investment for you.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...